ArticleWorld journal of urology2025
Predicting poor early voiding pattern after holep using maximum flow rate (Q-max) as an objective outcome.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Perioperative anesthetic management characteristics associated with early postoperative voiding recovery and short-term urinary outcomes after HoLEP in elderly frail patients: a retrospective study.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeHolmium laser enucleation of the prostate (HoLEP) is recognized as a gold standard treatment for benign prostatic hyperplasia (BPH), providing durable improvements in quality of life and symptomatology. However, a subset of patients continues to experience suboptimal voiding outcomes postoperatively. This study aims to identify preoperative predictors of poor voiding patterns, as objectively measured by maximum urinary flow rate (Q-max), following HoLEP.
methodsWe retrospectively analyzed 1121 patients who underwent HoLEP at McGill University Health Centre from January 2006 to December 2022. Inclusion required a minimum one-month follow-up with documented Q-max. Data collected included demographics, preoperative parameters (IPSS, PSA, prostate volume), operative details, and postoperative outcomes. Poor voiding was defined as a Q-max < 15 ml/sec at one month postoperatively. Bilateral stepwise regression identified candidate predictors, which were further evaluated using logistic regression.
resultsThe cohort had a mean age of 70.7 years (SD 8.3), mean prostate volume of 98.3 mL, and mean PSA of 6.7 ng/dL (SD 9.1). Preoperative medical therapy included alpha blockers (63.6%) and combination therapy (33%). Multivariate analysis revealed that advanced age (OR = 1.01 per year; 95% CI, 1.00-1.01; p = 0.017), diabetes mellitus (OR = 1.29; 95% CI, 1.03-1.62; p = 0.028), and preoperative combination BPH therapy (OR = 1.17; 95% CI, 1.02-1.34; p = 0.023) were independently associated with poor postoperative Q-max, whereas increased enucleated tissue weight was protective (OR = 0.998; 95% CI, 0.996-0.999; p = 0.005).
conclusionsAdvanced age, diabetes mellitus, and combination BPH therapy independently predict suboptimal voiding after HoLEP, highlighting the need for tailored preoperative evaluation and management strategies.
Indexed as
Identifiers
40736573What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.